基本信息
浏览量:241
职业迁徙
个人简介
DESCRIPTION OF RESEARCH:
Dr. Teh’s research focuses on the treatment of genito-urinary malignancies and unlocking the myth of radio-resistance in cancers especially renal cell carcinoma. Other research interests include Intensity modulated radiation therapy (IMRT) for prostate cancer, head and neck cancer, central nervous system tumor, pediatric cancer and breast cancer, stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), stereotactic radiation therapy (SRT) and image-guided radiation therapy (IGRT), brachytherapy for prostate cancer, breast cancer and endobronchial tumors, SRS and SBRT for primary and metastatic renal cell carcinoma as well as hepatocellular carcinoma, the role of combined radiotherapy and gene therapy for cancers including prostate cancer, renal cell carcinoma, bladder cancer, pancreatic cancer, glioblastoma multiforme, cervical cancer and head and neck cancer, combining targeted therapy (AKT-inhibitor, mTOR inhibitor, tyrosine kinase inhibitor) with radiotherapy for cancer treatment, and combining oncolytic virus with radiotherapy in overcoming radio-resistant tumors in oncology.
AREAS OF EXPERTISE:
Cancer stem cells Radio-resistance Prostate Movement study Post-prostatectomy IMRT Gene expression profiling in cancer Proteomics in oncology
Dr. Teh’s research focuses on the treatment of genito-urinary malignancies and unlocking the myth of radio-resistance in cancers especially renal cell carcinoma. Other research interests include Intensity modulated radiation therapy (IMRT) for prostate cancer, head and neck cancer, central nervous system tumor, pediatric cancer and breast cancer, stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), stereotactic radiation therapy (SRT) and image-guided radiation therapy (IGRT), brachytherapy for prostate cancer, breast cancer and endobronchial tumors, SRS and SBRT for primary and metastatic renal cell carcinoma as well as hepatocellular carcinoma, the role of combined radiotherapy and gene therapy for cancers including prostate cancer, renal cell carcinoma, bladder cancer, pancreatic cancer, glioblastoma multiforme, cervical cancer and head and neck cancer, combining targeted therapy (AKT-inhibitor, mTOR inhibitor, tyrosine kinase inhibitor) with radiotherapy for cancer treatment, and combining oncolytic virus with radiotherapy in overcoming radio-resistant tumors in oncology.
AREAS OF EXPERTISE:
Cancer stem cells Radio-resistance Prostate Movement study Post-prostatectomy IMRT Gene expression profiling in cancer Proteomics in oncology
研究兴趣
论文共 511 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Current oncology (Toronto, Ont.)no. 3 (2024): 1588-1599
Ximing J. Yang,Min-Han Tan,Hyung L. Kim,Jonathon A. Ditlev, Mark W. Betten, Carolina E. Png,Eric J. Kort,Kunihiko Futami,Kyle A. Furge,Masayuki Takahashi,Hiro-omi Kanayama,Puay Hoon Tan,
crossref(2023)
Chinese clinical oncologyno. 3 (2023): 29-29
引用0浏览0WOS引用
0
0
Andrew B. Barbour,Simon Kirste, Anca-Liga Grosu,Shankar Siva, Alexander V. Louie,Hiroshi Onishi,Anand Swaminath,Bin S. Teh,Sarah P. Psutka,Emily S. Weg,Jonathan J. J. Chen,Jing Zeng,
CANCERSno. 14 (2023): 3672-3672
Chinese clinical oncologyno. 3 (2023): 26
引用0浏览0WOS引用
0
0
CANCER RESEARCHno. 7 (2023)
引用0浏览0引用
0
0
crossref(2023)
crossref(2023)
Dan Huang,Yan Ding,Wang-Mei Luo, Stephanie Bender,Chao-Nan Qian,Eric Kort,Zhong-Fa Zhang,Kristin VandenBeldt, Nicholas S. Duesbery,James H. Resau,Bin Tean Teh
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn